1.
F Cervantes, JC Hernandez-Boluda, JL Steegmann, E Conde, A Alvarez-Larran, J Lopez-Jimenez, S Osorio, L Villalon, M Camos, J Garcia-Conde, J Odriozola. Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients. Haematologica 2003;88(10):1117-1122; https://doi.org/10.3324/%x.